Omada Health (NASDAQ:OMDA) CAO Craig Gracey Sells 2,084 Shares

Omada Health, Inc. (NASDAQ:OMDA) CAO Craig Gracey sold 2,084 shares of Omada Health stock in a transaction that occurred on Friday, June 26th. The shares were sold at an average price of $20.00, for a total value of $41,680.00. Following the transaction, the chief accounting officer owned 2,941 shares of the company’s stock, valued at approximately $58,820. This represents a 41.47% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link.

Craig Gracey also recently made the following trade(s):

• On Monday, June 29th, Craig Gracey sold 2,083 shares of Omada Health stock. The stock was sold at an average price of $21.00, for a total value of $43,743.00.
• On Wednesday, June 24th, Craig Gracey sold 2,083 shares of Omada Health stock. The stock was sold at an average price of $19.01, for a total transaction of $39,597.83.
• On Monday, June 22nd, Craig Gracey sold 2,083 shares of Omada Health stock. The shares were sold at an average price of $18.00, for a total transaction of $37,494.00.
• On Friday, June 12th, Craig Gracey sold 6,894 shares of Omada Health stock. The shares were sold at an average price of $17.42, for a total transaction of $120,093.48.

Omada Health Stock Performance

Shares of NASDAQ OMDA opened at $21.95 on Wednesday. The company has a market capitalization of $1.30 billion and a PE ratio of -81.30. The company’s fifty day moving average price is $16.83 and its 200 day moving average price is $14.93. Omada Health, Inc. has a 1 year low of $10.28 and a 1 year high of $26.92.

Omada Health (NASDAQ:OMDA) last released its quarterly earnings data on Thursday, May 7th. The company reported ($0.05) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.03. The company had revenue of $78.05 million during the quarter. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.82%. On average, equities analysts expect that Omada Health, Inc. will post -0.01 EPS for the current year.

Analysts Set New Price Targets

A number of research firms recently weighed in on OMDA. Wall Street Zen raised Omada Health from a “hold” rating to a “buy” rating in a report on Saturday. JPMorgan Chase & Co. dropped their price objective on Omada Health from $32.00 to $26.00 and set an “overweight” rating on the stock in a report on Thursday, March 12th. BMO Capital Markets cut their price objective on Omada Health from $27.00 to $18.00 and set an “outperform” rating for the company in a research report on Friday, March 6th. Citigroup reiterated an “outperform” rating on shares of Omada Health in a research report on Friday, May 8th. Finally, Evercore reissued an “outperform” rating and issued a $20.00 price target on shares of Omada Health in a research note on Friday, May 8th. Ten analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $22.91.

Hedge Funds Weigh In On Omada Health

A number of hedge funds have recently made changes to their positions in the company. Perceptive Advisors LLC acquired a new stake in shares of Omada Health in the second quarter worth approximately $44,402,000. Millennium Management LLC lifted its holdings in Omada Health by 1,195.0% in the 4th quarter. Millennium Management LLC now owns 2,272,168 shares of the company’s stock valued at $35,855,000 after purchasing an additional 2,096,705 shares in the last quarter. Loomis Sayles & Co. L P boosted its stake in Omada Health by 23.0% during the 4th quarter. Loomis Sayles & Co. L P now owns 1,855,721 shares of the company’s stock worth $29,283,000 after purchasing an additional 346,588 shares during the last quarter. Divisadero Street Capital Management LP acquired a new stake in shares of Omada Health in the third quarter valued at about $30,510,000. Finally, Jefferies Financial Group Inc. acquired a new stake in shares of Omada Health in the fourth quarter valued at about $16,948,000.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.